Fortis Escorts Faridabad introduces Cryo technique to treat lung cancer
Cryo-technology helps in early diagnosis and palliative care in later stages of cancer
Cryo-technology helps in early diagnosis and palliative care in later stages of cancer
Tecentriq is the first and only cancer immunotherapy approved for NSCLC in the adjuvant setting
When the Delfi technology was used as a pre-screen to determine if a low dose CT (LDCT), should be performed, the combined approach led to the detection of 90% of lung cancers, including 80% of stage I cancers
Osimertinib works by slowing or stopping the growth of cancer cells and binds to a certain protein (epidermal growth factor receptor-EGFR) in some tumors
Genomics is transforming the future of modern medicine and treatment modalities across specialties
Protein-bound Paclitaxel is indicated for the treatment of metastatic breast cancer, locally advanced or metastatic non-small cell lung cancer and metastatic adenocarcinoma of the pancreas
Subcutaneous pembrolizumab administered every six weeks with a median injection time of two minutes, in combination with chemotherapy, shows consistent results across reported efficacy and safety endpoints compared to IV KEYTRUDA in combination with chemotherapy
This program aims to develop a fully human monoclonal antibody against a novel immune checkpoint protein that enables T cell activation
The safety profile of Opdualag observed in this analysis was consistent with the known profiles of nivolumab and relatlimab
Regulatory filings underway for a third indication for darolutamide in prostate cancer, for finerenone in a common form of heart failure, and acoramidis in transthyretin amyloid
Subscribe To Our Newsletter & Stay Updated